BACKGROUND:Minimally invasive repair of pectus excavatum (MIRPE) is now performed in adults. Managing adult patients' pain postoperatively has been challenging due to increased chest wall rigidity and the pressure required for supporting the elevated sternum. The optimal pain management regimen has not been determined. We designed this prospective, randomized trial to compare postoperative pain management and outcomes between thoracic epidural analgesia (TEA) and bilateral subcutaneous infusion pump catheters (On-Q). METHODS:Patients undergoing MIRPE (modified Nuss) underwentrandom assignment to TEA or On-Q group. Both groups received intravenous, patient-controlled opioid analgesia, with concomitant delivery of local anesthetic. Primary outcomes were length of stay (LOS), opioid use, and pain scores. RESULTS: Of 85 randomly assigned patients, 68 completed the study [52 men, 76.5%; mean (range) age, 32.2 (20.0-58.0) years; Haller index, 5.9 (range, 3.0-26.7)]. The groups were equally matched for preoperative variables; however, the On-Q arm had more patients (60.3%). No significant differences were found between groups in mean daily pain scores (P=0.52), morphine-equivalent opioid usage (P=0.28), or hospital stay 3.5 vs. 3.3 days (TEA vs. On-Q; P=0.55). Thirteen patients randomized to TEA refused the epidural and withdrew from the study because they perceived greater benefit of the On-Q system. CONCLUSIONS:Postoperative pain management in adults after MIRPE can be difficult. Both continuous local anesthetic delivery by TEA and On-Q catheters with concomitant, intravenous, patient-controlled anesthesia maintained acceptable analgesia with a reasonable LOS. In our cohort, there was preference for the On-Q system for pain management.
RCT Entities:
BACKGROUND: Minimally invasive repair of pectus excavatum (MIRPE) is now performed in adults. Managing adult patients' pain postoperatively has been challenging due to increased chest wall rigidity and the pressure required for supporting the elevated sternum. The optimal pain management regimen has not been determined. We designed this prospective, randomized trial to compare postoperative pain management and outcomes between thoracic epidural analgesia (TEA) and bilateral subcutaneous infusion pump catheters (On-Q). METHODS:Patients undergoing MIRPE (modified Nuss) underwent random assignment to TEA or On-Q group. Both groups received intravenous, patient-controlled opioid analgesia, with concomitant delivery of local anesthetic. Primary outcomes were length of stay (LOS), opioid use, and pain scores. RESULTS: Of 85 randomly assigned patients, 68 completed the study [52 men, 76.5%; mean (range) age, 32.2 (20.0-58.0) years; Haller index, 5.9 (range, 3.0-26.7)]. The groups were equally matched for preoperative variables; however, the On-Q arm had more patients (60.3%). No significant differences were found between groups in mean daily pain scores (P=0.52), morphine-equivalent opioid usage (P=0.28), or hospital stay 3.5 vs. 3.3 days (TEA vs. On-Q; P=0.55). Thirteen patients randomized to TEA refused the epidural and withdrew from the study because they perceived greater benefit of the On-Q system. CONCLUSIONS:Postoperative pain management in adults after MIRPE can be difficult. Both continuous local anesthetic delivery by TEA and On-Q catheters with concomitant, intravenous, patient-controlled anesthesia maintained acceptable analgesia with a reasonable LOS. In our cohort, there was preference for the On-Q system for pain management.
Authors: Dawn Jaroszewski; David Notrica; Lisa McMahon; D Eric Steidley; Claude Deschamps Journal: J Am Board Fam Med Date: 2010 Mar-Apr Impact factor: 2.657
Authors: John C Densmore; Danielle B Peterson; Linda L Stahovic; Michelle L Czarnecki; Keri R Hainsworth; Hobart W Davies; Laura D Cassidy; Steven J Weisman; Keith T Oldham Journal: J Pediatr Surg Date: 2010-09 Impact factor: 2.545
Authors: Robert E Kelly; Michael J Goretsky; Robert Obermeyer; Marcia Ann Kuhn; Richard Redlinger; Tina S Haney; Alan Moskowitz; Donald Nuss Journal: Ann Surg Date: 2010-12 Impact factor: 12.969
Authors: Daniel P Croitoru; Robert E Kelly; Michael J Goretsky; M Louise Lawson; Barbara Swoveland; Donald Nuss Journal: J Pediatr Surg Date: 2002-03 Impact factor: 2.545
Authors: Thomas Weber; Johanna Mätzl; Alexander Rokitansky; Walter Klimscha; Konrad Neumann; Engelbert Deusch Journal: J Thorac Cardiovasc Surg Date: 2007-10 Impact factor: 5.209
Authors: Jelle E Bousema; Esther M Dias; Sander M Hagen; Bastiaan Govaert; Patrick Meijer; Frank J C van den Broek Journal: J Cardiothorac Surg Date: 2019-10-22 Impact factor: 1.637